About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Topiramate and Cerebrovascular Response in Migraineurs

Topiramate and Cerebrovascular Response in Migraineurs

NCT02424318·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

SMG-SNU Boramae Medical Center

Age

18–65

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

aged 18 to 65 years
newly-diagnosed patients with migraine without aura (International Headache Society classification)
symptom frequency (at least 2 episodes of migraine attack/month)

You may not be if

prior use of preventive medication
patients with cardiovascular risk factors (hypertension, diabetes, hyperlipidemia, smoking)
patients who take antihypertensive agent or antidepressant
patients who were pregnant, breast-feeding or actively smoking
patients with neurological or cerebrovascular diseases

The record

StatusCompleted

PhasePhase 4

Taking part19

StartedDec 2008

UpdatedApr 23, 2015

Conditions

Migraine Disorders